Company intelligence / Profile preview

BVF Acquisition

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

BVF Acquisition Corp. was a special purpose acquisition company (SPAC) formed by BVF Partners L.P., a prominent biotechnology-focused investment firm. The company was established to identify and merge with a high-growth business in the biotechnology or broader healthcare sector, leveraging the deep industry expertise of its sponsor. It completed its initial public offering in May 2021, raising approximately $200 million. However, after failing to consummate a business combination within the required timeframe, the company announced its liquidation and the redemption of its outstanding shares in March 2023. Consequently, the company is no longer active and its securities have been delisted from the Nasdaq.

Industry: Investors

Beyond the preview

Go deeper on BVF Acquisition.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BVF Acquisition.

Explore the full profile